von Hippel-Lindau disease: A clinical and scientific review

被引:440
作者
Maher, Eamonn R. [1 ,2 ,3 ]
Neumann, Hartmut P. H. [4 ]
Richard, Stephane [5 ,6 ,7 ]
机构
[1] Univ Birmingham, Coll Med & Dent Sci, Ctr Rare Dis & Personalised Med,Clin Genet Unit, Sect Med & Mol Genet,Inst Biomed Res, Birmingham B15 2TT, W Midlands, England
[2] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Dept Med & Mol Genet,Inst Biomed Res, Birmingham B15 2TT, W Midlands, England
[3] Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham, W Midlands, England
[4] Univ Freiburg, Univ Med Ctr, Sect Prevent Med, Dept Nephrol, Freiburg, Germany
[5] Hop Bicetre, AP HP, Serv Urol, Ctr Reference Canc Rares INCa PREDIR & Reseau Nat, Le Kremlin Bicetre, France
[6] Inst Cancerol Gustave Roussy, INSERM, U753, Genet Oncol EPHE, Villejuif, France
[7] Fac Med Paris Sud, Le Kremlin Bicetre, France
关键词
VHL; von Hippel-Lindau; haemangioblastoma; renal carcinoma; phaeochromocytoma; renal cysts; RENAL-CELL CARCINOMA; TUMOR-SUPPRESSOR GENE; GENOTYPE-PHENOTYPE CORRELATIONS; ENDOCRINE NEOPLASIA TYPE-2; RECEPTOR INHIBITOR SU5416; ENDOLYMPHATIC SAC TUMORS; CENTRAL-NERVOUS-SYSTEM; NATURAL-HISTORY; SPARING SURGERY; RETINAL HEMANGIOBLASTOMA;
D O I
10.1038/ejhg.2010.175
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The autosomal dominantly inherited disorder von Hippel-Lindau disease (VHL) is caused by germline mutations in the VHL tumour suppressor gene (TSG). VHL mutations predispose to the development of a variety of tumours (most commonly retinal and central nervous system haemangioblastomas, clear cell renal carcinoma and phaeochromocytomas). Here, we review the clinical and genetic features of VHL disease, briefly review the molecular pathogenesis and outline clinical management and tumour surveillance strategies.
引用
收藏
页码:617 / 623
页数:7
相关论文
共 76 条
[31]   Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase [J].
Kamura, T ;
Koepp, DM ;
Conrad, MN ;
Skowyra, D ;
Moreland, RJ ;
Iliopoulos, O ;
Lane, WS ;
Kaelin, WG ;
Elledge, SJ ;
Conaway, RC ;
Harper, JW ;
Conway, JW .
SCIENCE, 1999, 284 (5414) :657-661
[32]   VONHIPPEL-LINDAU DISEASE AND RENAL-CELL CARCINOMA IN A 16-YEAR-OLD BOY [J].
KEELER, LL ;
KLAUBER, GT .
JOURNAL OF UROLOGY, 1992, 147 (06) :1588-1591
[33]   Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein [J].
Kondo, K ;
Klco, J ;
Nakamura, E ;
Lechpammer, M ;
Kaelin, WG .
CANCER CELL, 2002, 1 (03) :237-246
[34]   Psychosocial impact of Von Hippel-Lindau disease: levels and sources of distress [J].
Lammens, C. R. M. ;
Bleiker, E. M. A. ;
Verhoef, S. ;
Hes, F. J. ;
Ausems, M. G. E. M. ;
Majoor-Krakauer, D. ;
Sijmons, R. H. ;
van der Luijt, R. B. ;
van den Ouweland, A. M. W. ;
Van Os, Tam ;
Hoogerbrugge, N. ;
Garcia, E. B. Gomez ;
Dommering, C. J. ;
Gundy, C. M. ;
Aaronson, N. K. .
CLINICAL GENETICS, 2010, 77 (05) :483-491
[35]   IDENTIFICATION OF THE VONHIPPEL-LINDAU DISEASE TUMOR-SUPPRESSOR GENE [J].
LATIF, F ;
TORY, K ;
GNARRA, J ;
YAO, M ;
DUH, FM ;
ORCUTT, ML ;
STACKHOUSE, T ;
KUZMIN, I ;
MODI, W ;
GEIL, L ;
SCHMIDT, L ;
ZHOU, FW ;
LI, H ;
WEI, MH ;
CHEN, F ;
GLENN, G ;
CHOYKE, P ;
WALTHER, MM ;
WENG, YK ;
DUAN, DSR ;
DEAN, M ;
GLAVAC, D ;
RICHARDS, FM ;
CROSSEY, PA ;
FERGUSONSMITH, MA ;
LEPASLIER, D ;
CHUMAKOV, I ;
COHEN, D ;
CHINAULT, AC ;
MAHER, ER ;
LINEHAN, WM ;
ZBAR, B ;
LERMAN, MI .
SCIENCE, 1993, 260 (5112) :1317-1320
[36]   Neuronal apoptosis linked to EgIN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer [J].
Lee, S ;
Nakamura, E ;
Yang, HF ;
Wei, WY ;
Linggi, MS ;
Sajan, MP ;
Farese, RV ;
Freeman, RS ;
Carter, BD ;
Kaelin, WG ;
Schlisio, S .
CANCER CELL, 2005, 8 (02) :155-167
[37]   The worldwide distribution of the VHL 598C>T mutation indicates a single founding event [J].
Liu, EL ;
Percy, MJ ;
Amos, CI ;
Guan, YL ;
Shete, S ;
Stockton, DW ;
McMullin, MF ;
Polyakova, LA ;
Ang, SO ;
Pastore, YD ;
Jedlickova, K ;
Lappin, TRJ ;
Gordeuk, V ;
Prchal, JT .
BLOOD, 2004, 103 (05) :1937-1940
[38]   Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease [J].
Lonser, RR ;
Weil, RJ ;
Wanebo, JE ;
DeVroom, HL ;
Oldfield, EH .
JOURNAL OF NEUROSURGERY, 2003, 98 (01) :106-116
[39]   von Hippel-Lindau disease [J].
Lonser, RR ;
Glenn, GM ;
Walther, M ;
Chew, EY ;
Libutti, SK ;
Linehan, WM ;
Oldfield, EH .
LANCET, 2003, 361 (9374) :2059-2067
[40]   Von Hippel-Lindau disease [J].
Maher, ER .
CURRENT MOLECULAR MEDICINE, 2004, 4 (08) :833-842